Pltr Nasdaq 100 Investment Opportunities and Risks

Author

Reads 904

Woman Sitting on a Sofa with a Laptop Displaying a Chart
Credit: pexels.com, Woman Sitting on a Sofa with a Laptop Displaying a Chart

Investing in the Pltr Nasdaq 100 can be a lucrative opportunity, but it's essential to understand the associated risks.

The Pltr Nasdaq 100 is a popular investment option, with a significant portion of its value tied to the performance of the top 100 companies listed on the Nasdaq stock exchange.

One of the primary risks of investing in the Pltr Nasdaq 100 is market volatility, which can cause the value of your investment to fluctuate rapidly.

The Pltr Nasdaq 100 has historically been affected by economic downturns, such as the 2008 financial crisis, highlighting the importance of diversification in your investment portfolio.

Investment Analysis

Analysts have a Hold consensus rating on Palantir Technologies stock based on three Buys, eleven Holds, and four Sells assigned in the past three months.

The average PLTR stock price target is $100.13, implying downside potential of 18.14%.

Analysts have a mixed view on PLTR stock, with three Buys and four Sells assigned in the past three months.

The consensus rating is based on the opinions of multiple analysts, providing a comprehensive view of the stock's prospects.

Stock Performance

Credit: youtube.com, Palantir Joins the Nasdaq-100: What It Means for Investors!

Palantir stock has seen significant price performance in recent periods. The 1-month period saw a performance of +8.93 (+12.58%) since 12/03/24.

Looking at the 3-month period, we can see a substantial increase in price, with a performance of +40.65 (+103.59%) since 10/03/24.

Over the 52-week period, Palantir stock has experienced a remarkable growth of +63.80 (+396.52%) since 01/03/24.

Here's a breakdown of the price performance over different time periods:

The recent third-quarter report from Palantir sent shares soaring more than 24% the next day, a testament to the company's strong performance.

Options and Trading

As we dive into the world of options and trading with PLTR on the NASDAQ 100, it's essential to understand the current state of implied volatility, which has increased by 8.18% to 68.23%. This significant spike indicates a rise in market uncertainty.

Implied volatility is a crucial metric for traders, and in this case, it's 75th percentile, suggesting that it's higher than average. However, it's still 63.50% below its peak of 86.10% on August 5th.

Readers also liked: Brk B Pe Ratio

Credit: youtube.com, Palantir & HOOD Stock ALERT - Huge Announcement!

The put-call volume ratio is a key indicator of market sentiment, and currently, it's 0.84, which means that for every 1 call option traded, 0.84 put options are traded. This suggests that investors are slightly more bearish than bullish.

The daily trading volume is substantial, with 805,293 shares changing hands today, and the average volume over the past 30 days is 820,337. This indicates a relatively stable trading environment.

Here's a breakdown of the put-call volume ratio and open interest:

These numbers provide a snapshot of the current market activity and sentiment, which can be useful for traders looking to make informed decisions.

Nasdaq 100 Listing

Palantir's inclusion in the Nasdaq-100 index is a significant milestone.

This means mutual funds, exchange-traded funds (ETFs), and other financial products based on this index will have to buy shares of Palantir, exerting upward pressure on the stock price.

Palantir's visibility is expected to increase with membership in this well-known stock index, widening the pool of potential investors in its stock.

Credit: youtube.com, Palantir is about to make Investors WEALTHY! Nasdaq 100 Listing on Nov 26 $PLTR Analysis

Over the last decade, companies added to the Nasdaq-100 saw an average 17% share price increase within the following 12 months.

Palantir's addition to the index is almost certain, given its status as the largest Nasdaq-listed company not currently in the index.

As a result, Palantir investors got some good news, with the company's stock already having soared 343% in 2024.

You might like: Google Company Strategy

Investor Insights

Palantir's stock has seen a significant surge in recent times, with a 24% increase in shares following a fantastic third-quarter report. The company's revenue and adjusted earnings per share (EPS) surged 30% and 43% respectively, beating Wall Street's estimates.

Analysts have a Hold consensus rating on Palantir Technologies stock, with an average stock price target of $100.13, implying downside potential of 18.14%. This suggests that while some analysts are optimistic about the company's long-term prospects, others are cautious about its valuation.

Several analysts, including Morningstar's Mike Giarelli and Wedbush's Daniel Ives, remain upbeat about Palantir's long-term prospects, citing its expanding role in federal AI initiatives and its potential to benefit from government AI spending.

Explore further: Apple Company Growth Rate

Fundamentals

Credit: youtube.com, Investing Fundamentals | Investing Insights | Chapter 01 | Alfonso Cahero

Investors often focus on a company's fundamentals to gauge its overall health and potential for growth. Market capitalization stands at $181,991,104, a significant figure that indicates the company's size and value.

The number of shares outstanding is substantial, with 2,278,021 shares available. This can impact the stock's price and volatility.

Annual sales of $2,225 million provide a clear picture of the company's revenue stream. This figure has likely been influenced by the company's EBIT, which is $365 million.

A 60-month beta of 2.82 suggests that the company's stock price can be volatile, moving up or down significantly in response to market changes. This is a key consideration for investors looking to mitigate risk.

The price-to-sales ratio of 72.62 indicates that the company's stock price is relatively high compared to its revenue. This could be a warning sign for investors.

Here's a breakdown of the company's key financial metrics:

The price-to-earnings ratio of 469.94 is notably high, indicating that investors are willing to pay a premium for the company's stock. This could be driven by expectations of future growth.

Analysts' Views

Credit: youtube.com, Investor Insights Podcast #61 – Geoffrey Hsu, Portfolio Manager of the Biotech Growth Trust

Analysts have a Hold consensus rating on Palantir Technologies stock based on three Buys, eleven Holds, and four Sells assigned in the past three months. This suggests that many experts are cautious about the stock's current valuation.

The average PLTR stock price target is $100.13, implying a potential downside of 18.14% from the current price. This is a significant warning sign for investors.

Analysts have forecasted adjusted earnings growth of 27% annually through 2025, which is far below what's needed to justify the current stock price. This is a key concern for investors.

A staggering 220 times adjusted earnings is the valuation multiple of Palantir's stock. This is extremely high and raises concerns about the stock's sustainability.

Here's a breakdown of analyst consensus:

Some analysts remain upbeat about Palantir's long-term prospects, with Morningstar's Mike Giarelli calling it "the next software juggernaut." However, even the bulls are cautious about the stock's valuation.

Palantir Stock Investors Reaping Benefits

Credit: youtube.com, Next Palantir? Top 3 Defense Stocks Under $10 to Watch with Huge Potential in 2025 ‼️🚀

Palantir stock investors have had a remarkable run recently, with the company's third-quarter report sending shares soaring over 24% in a single day.

Palantir's revenue and adjusted earnings per share surged 30% and 43% respectively, beating Wall Street's estimates.

The third-quarter report was a significant milestone for Palantir, as it marked a 30% year-over-year increase in revenue and a 43% jump in adjusted earnings per share.

Management also increased full-year 2024 guidance for revenue, adjusted operating profit, and adjusted free cash flow, providing further evidence of the company's growth potential.

Palantir's inclusion in the Nasdaq-100 index is a testament to its impressive performance in 2024, with the stock soaring 343% through December 13.

This move is expected to increase demand for Palantir's shares, exerting upward pressure on the stock price.

Palantir's visibility is set to increase with its membership in the Nasdaq-100 index, attracting a wider pool of potential investors to its stock.

See what others are reading: Consumer Reports Medigap 2024

Credit: youtube.com, Palantir Set to Make A HUGE Move This Week!

Palantir's recent $795 million deal with the U.S. Army for the Maven Smart System has pushed the total value of its work on Maven to about $1.3 billion, marking its first billion-dollar contract.

This deal is a major lift for Palantir, cementing its role in global defense systems and highlighting its deep involvement in defense and national security.

Palantir's financial momentum remains strong, with revenue surging 39% year-over-year to $883.85 million in Q1 2025, topping forecasts by nearly $22 million.

The company's U.S. commercial sales jumped 71% to $255 million, while U.S. government revenue climbed 45% to $373 million.

Palantir's growth is also fueled by its inclusion in the Nasdaq-100 index, which has historically led to significant stock gains for companies added to the index.

For your interest: Brk B Book Value

Short-term gains, long-term risks

Palantir's stock price has been soaring, but analysts are skeptical about its valuation. The stock trades at an astonishing 220 times adjusted earnings.

Many analysts believe the stock is overvalued, with a median 12-month price target of just $38 per share, representing a 50% downside from the current price. This reflects a broad consensus among analysts, with all 20 following Palantir agreeing the stock is overvalued.

Credit: youtube.com, Gary Shilling explains the only way to beat the market and win

The Nasdaq-100 inclusion could provide a short-term boost to Palantir's stock price, driven by index-related buying and investor momentum. However, its sky-high valuation remains unsustainable, posing a significant correction risk in the future.

To put this into perspective, even the most optimistic price target among analysts is just $75 per share, representing a 2% downside from the current price. This suggests that investors should be cautious and weigh the short-term excitement against the long-term fundamentals before making a decision.

For your interest: Pltr Short Interest

Catalysts for Growth

Palantir's growth has been driven by several key catalysts. One of the biggest strengths of the company is its deep role in defense and national security, which recently got a major lift with a new $795 million deal for the Maven Smart System.

The company has also kept up its strong financial momentum, beating earnings estimates for seven straight quarters. Revenue surged 39% year-over-year to $883.85 million in Q1 2025, topping forecasts by nearly $22 million.

Consider reading: Krugerrand Value by Year

Credit: youtube.com, Custom Catalysts Market Analysis with Growth Forecast during 2019-2025

U.S. commercial sales led the growth, jumping 71% to $255 million, while U.S. government revenue climbed 45% to $373 million. Adjusted EPS came in at $0.13, in line with expectations.

Palantir has raised its full-year revenue outlook to as high as $3.9 billion, well above both its previous forecast and Wall Street estimates. This strong performance has fueled investor confidence and contributed to the stock's sharp rise this year.

A significant shift has also taken place with Palantir's listing on the Nasdaq Exchange, positioning the company for inclusion in the Nasdaq-100 index. History suggests that companies added to the index see an average 17% share price increase within the following 12 months.

Technical Analysis

Palantir Technologies (PLTR) shares have been on a tear, more than quadrupling from the start of the year as of Friday's close. The stock's inclusion into the Nasdaq 100 Index is a significant milestone, and investors are likely watching key price levels closely.

Credit: youtube.com, NASDAQ 100 Analysis: NASDAQ Continues to Rally

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction. Long term indicators fully support a continuation of the trend.

The relative strength index (RSI) confirms bullish momentum, but its elevated reading above 80 cautions overbought conditions, which could lead to near-term price fluctuations.

Palantir shares have continued to trend sharply higher after breaking out from a cup and handle pattern. The measuring principle projects a bullish price target of $140.07.

Here are key levels to watch during retracements:

  • Initial support around $45, where investors may seek buying opportunities near a brief period of consolidation in the stock during October.
  • A zone of support between $33 and $29, which would likely attract buying interest near the cup and handle pattern's top trendline and the upward sloping 50-week moving average.

Stock Management

Palantir is a software-as-a-service (SaaS) company that provides AI-powered software over the cloud.

Its platforms enable customers to use their data to increase operational effectiveness and efficiency, and its customers include agencies within the U.S. government and those of our allies and commercial customers.

The Nasdaq-100 has a long history, launched in 1985.

Three stocks are being removed from the Nasdaq-100: Super Micro Computer, Illumina, and Moderna.

Additional reading: Customers Bank Asset Size

Credit: youtube.com, Palantir Joins Nasdaq 100 - Should You Buy Now?

Super Micro Computer's shares are up 28% through Dec. 13, 2024, but have plunged 69% since hitting their all-time high in March.

The stock's big drop is partly due to the weakening of some of its financial metrics, and mainly stems from the fallout following a well-known short-seller's allegations of accounting manipulations and other items of concern to investors.

Illumina is a genomics-focused biotech, and Moderna is best known as the maker of one of the two mRNA-based COVID-19 vaccines.

Maurice Pollich

Senior Writer

Maurice Pollich is a seasoned writer with a keen interest in the digital world. With a background in technology and finance, he brings a unique perspective to his writing. Maurice's expertise spans a range of topics, including cryptocurrency tokens, where he has developed a deep understanding of the underlying mechanics and market trends.

Love What You Read? Stay Updated!

Join our community for insights, tips, and more.